MGX earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -0.54. Updated 2026-07-23.
Metagenomi, Inc. Common Stock (MGX) Research Hub
Metagenomi, Inc. Common Stock (MGX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.16 USD (+0.87%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.54, market cap 0.05B. This hub links to the full technical, earnings and options research available for MGX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.16 USD (+0.87%) |
| 52-week range | 1.13 USD – 1.36 USD |
| Trend regime | Range |
| 14-day RSI | 33.3 (Bearish) |
| Trailing P/E | -0.54 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for MGX
Covered Call on MGX: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MGX: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MGX: how it works, illustrative setup around the real 1.16 USD price, max profit/loss, breakeven and when to use it. Educational.
MGX technical analysis: range, last 1.16 USD, RSI 33.3, 52w range 1.13 USD–1.36 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MGX in?
Metagenomi, Inc. Common Stock (MGX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MGX in an uptrend or downtrend?
As of 2026-09-11, MGX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MGX's trailing P/E ratio?
MGX's trailing P/E is -0.54, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does MGX next report earnings?
MGX is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.55307 USD.